Managing Acne in the LGBTQ+ Population
One of the most vulnerable populations among both teenagers and adults today is the LGBTQ community. An estimate of the LGBTQ population is difficult to solidify, but based on survey data it is estimated that sexual and gender minority individuals collectively represent four percent of the general population. The LGBTQ community is more likely to experience both dysphoria and discrimination, and t …
One of the most vulnerable populations among both teenagers and adults today is the LGBTQ community. An estimate of the LGBTQ population is difficult to solidify, but based on survey data it is estimated that sexual and gender minority individuals collectively represent four percent of the general population. The LGBTQ community is more likely to experience both dysphoria and discrimination, and t … 
Dr. Lester is the Director of the Skin of Color Program at the Department of Dermatology University of California San Francisco. Wow! This means we got a “two for one special” from her lecture, not only learning about the truths and myths associated with the use of isotretinoin in acne but also recognizing that those who are underrepresented minorities or socioeconomically disadvantaged may no … 
The skin findings in COVID-19 patients include a morbilliform rash, urticaria, vesicular eruptions, acral lesions (COVID toes), livedoid eruptions, and other nonspecific skin findings.
Skin findings of COVID-19 disease are similar to the cutaneous findings in other viral infections. Some of the skin findings are more commonly associated with COVID-19 infection than with other viruses sugg … 
As recent dermatology residency graduates like myself are well aware, the landscape is set – we will be taking our boards in October. Admittedly, when the ABD (American Board of Dermatology) inquired about when residents would like to take the exam, I responded – “July, please”. But as an entity that must look out for the interests of everyone while navigating the challenges of this pand … 
INTRODUCTION
Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic … 